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(IQR 10-17) vs. 16 (11-19); p = 0.23. IgG-NP values were significantly lower in KTR compared to 
immunocompetent controls: median IgG-NP ratio 25 (IQR 15-39) vs. 40 (IQR 28-42); p = 0.01.  
Our results suggest that KTR develop SARS-CoV-2 antibodies with equal neutralizing antibody 
capacity compared to immunocompetent subjects. 
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ABO incompatible (ABOi) living donor liver transplantation (LDLT) has been performed to compensate 
for donor shortage. To date, few studies have reported detailed results of ABOi LDLT in large series 
of pediatric patients. Complement C4d deposition in graft capillaries has been reported to be 
associated with antibody-mediated rejection in solid organ transplantation.  
Thirty-four pediatric ABOi LDLT recipients were retrospectively analysed by a case-control study. We 
compared the clinical outcomes of 34 ABOi pediatric recipients, each with 2 non-ABOi recipients 
(n=68) matched for the criteria of pre-transplant diagnosis, age, and date at the time of 
transplantation. Furthermore, we investigated the C4d immunostaining pattern in 22 ABOi and in 36 
non-ABOi recipients whose liver biopsy was taken within the first 4 post-transplant weeks for 
suspected acute rejection. Results: The incidence of biliary complications was higher among ABOi 
recipients (p<0.05), as the incidence of acute vascular rejection (p<0.01), and the incidence of 
retransplantation (p<0.05). All children who required a retransplantation were over 1 year old at the 
time of the ABOi LDLT. Positive C4d immunostaining was seen in 13/22 (59%) ABOi recipients, versus 
in 3/36 (8.3%) non-ABOi recipients (p<0.0001).  
ABO incompatible LDLT is a feasible option for pediatric end-stage liver disease, but entails increased 
risks for the recipient, especially for children older than 1 year, even with specific preparation 
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The annual balance between imports and exports of grafts is a matter of debate. We examined the 
Eurotransplant database of all liver grafts procured within Belgium and Luxemburg which were 
exported and transplanted abroad. The aim of our study was to analyse the reasons for graft refusal 
by all Belgian transplant centres and early postoperative evolution. Database between 2015 and 2019 
included donor characteristics, reason of offer decline, graft and recipient survival. During the 4 year 
period 329 grafts were procured in Belgium and transplanted abroad. 163 were exported for HU 
recipients, 17 no national match recipients (8 AB group, 2 pediatric and 7 other reasons), 19 pay back, 
15 splits, 11 not mentioned. Hundred and four grafts were declined by all Belgian centres. Forty seven 
were declined primary offers and fifty seven livers were distributed by extended allocation. Between 
them we find out four DCD donors, 83 for medical reasons (age, cytolysis, size mismatch and 
steatosis). Thirteen livers were accepted and declined at arrival for size mismatch (kept as rescue 
offer in the same centre). One donor was unstable and two were rejected for positive HCV virology. 
Only one liver who was primary accepted for a split was transplanted as a whole liver. Two patients 
presented primary graft nonfunction and three primary graft dysfunction. All of them were 
retransplanted. Thirteen patients died in the early 3 month postoperative period. Even though higher 
mortality is expected from marginal grafts, better acceptance rate could be achieved at a national 
level. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
